CISPLATIN\CYTARABINE\DEXAMETHASONE: 169 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
169
Total FAERS Reports
23 (13.6%)
Deaths Reported
27
Hospitalizations
169
As Primary/Secondary Suspect
12
Life-Threatening
8
Disabilities
First Report: 20110101 · Latest Report: 20230101
What Are the Most Common CISPLATIN\CYTARABINE\DEXAMETHASONE Side Effects?
#1 Most Reported
Off label use
49 reports (29.0%)
#2 Most Reported
Lymphoma
46 reports (27.2%)
#3 Most Reported
Disease progression
32 reports (18.9%)
All CISPLATIN\CYTARABINE\DEXAMETHASONE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 49 | 29.0% | 5 | 10 |
| Lymphoma | 46 | 27.2% | 3 | 7 |
| Disease progression | 32 | 18.9% | 2 | 2 |
| Cytomegalovirus infection reactivation | 22 | 13.0% | 0 | 0 |
| Neutropenia | 19 | 11.2% | 8 | 12 |
| Sepsis | 17 | 10.1% | 14 | 9 |
| Malignant neoplasm progression | 15 | 8.9% | 1 | 0 |
| Neuropathy peripheral | 13 | 7.7% | 0 | 7 |
| Product use issue | 13 | 7.7% | 2 | 3 |
| Renal failure | 13 | 7.7% | 2 | 9 |
| Pyrexia | 12 | 7.1% | 0 | 6 |
| Acute graft versus host disease in skin | 11 | 6.5% | 0 | 0 |
| Cystitis viral | 11 | 6.5% | 0 | 0 |
| Febrile neutropenia | 11 | 6.5% | 2 | 8 |
| Human polyomavirus infection | 11 | 6.5% | 0 | 0 |
| Myelosuppression | 11 | 6.5% | 8 | 7 |
| Ototoxicity | 11 | 6.5% | 0 | 0 |
| Thrombocytopenia | 11 | 6.5% | 4 | 5 |
| Varicella zoster virus infection | 11 | 6.5% | 0 | 0 |
| Diffuse large b-cell lymphoma recurrent | 10 | 5.9% | 3 | 5 |
Who Reports CISPLATIN\CYTARABINE\DEXAMETHASONE Side Effects? Age & Gender Data
Gender: 39.7% female, 60.3% male. Average age: 56.6 years. Most reports from: DE. View detailed demographics →
Is CISPLATIN\CYTARABINE\DEXAMETHASONE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 3 | 0 | 0 |
| 2012 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 0 |
| 2017 | 14 | 0 | 7 |
| 2018 | 9 | 0 | 0 |
| 2019 | 8 | 0 | 3 |
| 2020 | 7 | 4 | 4 |
| 2022 | 24 | 4 | 0 |
| 2023 | 1 | 0 | 0 |
What Is CISPLATIN\CYTARABINE\DEXAMETHASONE Used For?
| Indication | Reports |
|---|---|
| Diffuse large b-cell lymphoma | 129 |
| Mantle cell lymphoma | 12 |
| Follicular lymphoma | 10 |
CISPLATIN\CYTARABINE\DEXAMETHASONE vs Alternatives: Which Is Safer?
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CITALOPRAM
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CITALOPRAM HYDROBROMIDE
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CITALOPRAM\CITALOPRAM HYDROBROMIDE
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CITICOLINE
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CITRIC ACID
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CITRIC ACID\LACTIC ACID, L-\POTASSIUM
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CLADRIBINE
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CLARAVIS
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CLARITHROMYCIN
CISPLATIN\CYTARABINE\DEXAMETHASONE vs CLARITIN
Official FDA Label for CISPLATIN\CYTARABINE\DEXAMETHASONE
Official prescribing information from the FDA-approved drug label.